news
Founded in 2017, Lacerta has just opened a brand-new R&D laboratory facility custom built to our specifications in the heart of Alachua, Florida.
UCB strengthens its gene therapy activities with additional pipeline programs, capabilities and platforms
BRUSSELS, Nov. 12, 2020 /PRNewswire/ — UCB today announced the acquisition of Handl Therapeutics BV, a rapidly growing and transformative gene therapy company based in Leuven, Belgium and a new …
Lacerta Therapeutics Signs Gene Therapy Research Partnership with UCB
New research collaboration and licensing agreement with Lacerta provides UCB access to a novel gene therapy program and proprietary AAV capsids ALACHUA, Fla., November 12, …
Concept Companies Unveils New Office for Lacerta Therapeutics in Alachua’s Copeland Park
Link to article ALACHUA, Fla., Oct. 8, 2020 /PRNewswire/ — Gainesville-based developer Concept Companies has completed construction on a new 12,950-square-foot office and lab building in Copeland Park …
Gene therapy startup Lacerta Therapeutics raises $30M in equity financing from Sarepta
Sarepta Therapeutics gains rights to University of Florida-resident startup’s programs for central nervous system diseases. By Alaric DeArment August 14, 2018 – A startup based out …
UF Innovate | Sid Martin Biotech Resident Company Lacerta Therapeutics, Inc. Closes On $30 million Investment Round
GAINESVILLE, Fla.–(BUSINESS WIRE)–UF Innovate | Sid Martin Biotech, the leading biotechnology incubator at the University of Florida, announces resident company Lacerta Therapeutics, Inc., has closed on …
Sarepta Therapeutics Signs Long-term Strategic Investment and License Agreements with Lacerta Therapeutics
Press Release August 8, 2018 at 4:01 PM EDT Sarepta Therapeutics Signs Long-term Strategic Investment and License Agreements with Lacerta Therapeutics, Gaining Rights to Multiple …